SEC Comment Letter 0000000000-22-012914 to Scienture Holdings, Inc. (SCNX)

Scienture Holdings, Inc.
Date: Nov. 30, 2022 · CIK: 0001382574 · Accession: 0000000000-22-012914

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-268574

Date

November 30, 2022

Author

Suren Ajjarapu

Form

UPLOAD

Company

Scienture Holdings, Inc.

Letter

United States securities and exchange commission logo November 30, 2022 Suren Ajjarapu Chief Executive Officer TRxADE HEALTH, INC 2420 Brunello Trace Lutz, Florida 33558 Re:TRxADE HEALTH, INC Registration Statement on Form S-1 Filed November 28, 2022 File No. 333-268574 Dear Suren Ajjarapu: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Rucha Pandit at (202) 551-6022 with any questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc: David Loev

Show Raw Text

United States securities and exchange commission logo
November 30, 2022
Suren Ajjarapu
Chief Executive Officer
TRxADE HEALTH, INC
2420 Brunello Trace
Lutz, Florida 33558
Re:TRxADE HEALTH, INC
Registration Statement on Form S-1
Filed November 28, 2022
File No. 333-268574
Dear Suren Ajjarapu:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Rucha Pandit at (202) 551-6022 with any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc:       David Loev

SecProbe.io